Using a Geriatric Oncology Assessment to Link With Services

Cancer Clinical Trial

— GOAL  

Official title:

Using a Geriatric Oncology Assessment to Link With Services (GOAL)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02906592
• Other study ID #: Pro00073547
• Status: Completed
• Phase: N/A
• First received: September 15, 2016
• Last updated: January 9, 2018
• Start date: January 2017
• Est. completion date: September 29, 2017

Study information

• Verified date: April 2017
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this study is to implement a brief geriatric oncology assessment (GOA) in a community-based oncology clinic, the Scotland Cancer Treatment Center - a clinic within the Duke Cancer Network, located in the rural, low resource Scotland County community of North Carolina. Secondly, the investigators will evaluate the effectiveness of the brief GOA by comparing historical and post-GOA service referral patterns and adherence to planned cancer therapy. For this study, the investigators will prospectively enroll up to 60 patients who have been diagnosed and/or treated for cancer to complete the brief GOA. In addition to these 60 patients, the investigators will also conduct retrospective chart reviews on 120 patients that would be eligible for this study to evaluate past referral patterns. Eligible and consented patients will complete the brief GOA at the Scotland Cancer Treatment Center alongside their normal clinic appointment. The investigators will assess impact on the healthcare system by evaluating referral patterns (i.e., how many, what type of services) using the brief GOA data and EHR data. The study value includes the possibility for recognition and access to additional health care referrals if needed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: September 29, 2017
• Est. primary completion date: September 29, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

In order to be included in the project, patients must be:

1. Diagnosed for a solid tumor cancer (breast, lung, colon, rectal, colorectal (unspecified), pancreas, esophageal)

2. Diagnosis date within 12 months of identification

3. Receiving care at Scotland Cancer Treatment Center

4. Aged 60 years or older at the time of the visit

5. Planned therapy in the medical oncology clinic at the Scotland Cancer Treatment Center

Exclusion Criteria:

1. Diagnosis of metastatic cancer with <12 months life expectancy

2. Planned cancer therapy as surgery only

3. Receiving palliative or hospice care services (i.e., proxy for <12 months life expectancy)

4. Language (not proficient in English)

5. Nursing home/long-term care facility resident

6. Active diagnosis of psychosis (has been hospitalized in the last 30 days), schizophrenia, severe intellectual or developmental disabilities, or dementia

7. Patient deemed not fit/good candidate for study per provider recommendation

Related Conditions & MeSH terms

• Cancer

Locations

Country	Name	City	State
United States	Scotland Cancer Treatment Center	Laurinburg	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	Duke Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in referral patterns	Comparison of historical and post GOA service referral patterns	retrospective data from 1/1/2013-7/7/2016
Primary	Time to complete the brief GOA		6 months
Primary	Number of referrals completed		6 months
Primary	Number of patients who needed help completing the brief GOA		6 months